Strains |
|
|
S. erythraea NRRL2338 |
Used as parental strain, wild type |
DSM 40517 |
S. erythraea ΔpccD
|
S. erythraea SACE_3396 null mutant, thiostrepton resistant |
29 |
S. erythraea WT/pIB-pccD
|
SACE_3396 overexpression strain, WT carrying pIB-pccD
|
29 |
S. erythraea WT/pIB139 |
WT carrying vector pIB139 |
This study |
S. erythraea ΔpccD/pIB-pccD
|
SACE_3396 complementation strain, ΔpccD carrying pIB-pccD, which is under the control of pccD promoter |
This work |
S. erythraea ΔpccD/pIB139 |
Empty plasmid control, ΔpccD carrying pIB139 |
This study |
S. erythraea ΔgdhA1
|
S. erythraea SACE_3882 null mutant |
This study |
S. erythraea ΔgdhA1/pIB-gdhA1
|
gdhA1 complementation strain, ΔgdhA1 carrying pIB-gdhA1
|
This study |
S. erythraea ΔgdhA1/pIB139 |
Empty plasmid control, ΔgdhA1 carrying pIB139 whose ermE* promoter was replaced by SACE_3880–3884 promoter |
This study |
S. erythraea ΔbcdhE1
|
S. erythraea SACE_3884 null mutant |
This study |
S. erythraea ΔbcdhE1/pIB-bcdhE1
|
bcdhE1 complementation strain, ΔBcdhE1 carrying pIB-BcdhE1 gene |
This study |
S. erythraea ΔbcdhE1/pIB139 |
The empty plasmid control, ΔBcdhE1 gene carrying pIB139 whose ermE* promoter was replaced by SACE_3880–3884 promoter |
This study |
S. erythraea WT/pIB-bkd
|
SACE_3880–3884 overexpression strain, WT carrying pIB-bkd
|
This study |
E. coli Rosetta (DE3) |
F−
ompT hsdSB(rB− mB−) gal dcm λ(DE3)pRARE2(Camr) |
Novagen |
S. erythraea E3 |
Industrial high-erythromycin-producing strain |
SKLBE, ECUST |
S. erythraea E3ΔpccD
|
S. erythraea E3 SACE_3396 null mutant, thiostrepton resistant |
This study |
S. erythraea E3ΔpccD/pIB-bkd
|
SACE_3880–3884 overexpression strain, E3ΔpccD carrying pIB-bkd
|
This study |
S. erythraea WT/pKC-egfp |
egfp overexpression strain, WT carrying pKC-egfp |
This study |
Plasmids |
|
|
pET19b |
Expression vector, Ampr
|
Novagen |
pET-pccD
|
pET19b derivative carrying SACE_3396 |
29 |
pKC1139 |
acc(3)IV, pSG5, pBR322, oriTRK2
|
49 |
pIB139 |
E. coli-S. erythraea integrative shuttle vector containing a strong constitutive ermE* promoter, apramycin resistance |
50 |
pIB-pccD
|
pIB139 carrying an extra SACE_3396 for overexpression (under the control of the ermE* promoter)/complementation (under the control of pccD promoter) |
29; this study |
pIB-gdhA1
|
pIB139 carrying an extra SACE_3882 for complementation under the control of SACE_3880–3884 promoter |
This study |
pIB-BcdhE1 |
pIB139 carrying an extra SACE_3884 for complementation under the control of SACE_3880–3884 promoter |
This study |
pIB-bkd
|
pIB139 carrying an extra SACE_3880–3884 for gene overexpression |
This study |
pIB-egfp
|
pIB139 carrying an extra egfp gen for gene overexpression |
This study |
pUC-fd term |
pUC57 carrying a synthetic fd terminator gene originating from bacteriophage |
This study |
pUC19-tsr
|
pUC19 derivative containing a 1.36-kb fragment of a thiostrepton resistance cassette in the BamHI/SmaI sites |
51 |
pUC-pccD
|
pUC19-tsr, with the 1.5-kb DNA fragments upstream and downstream of the pccD gene inserted upstream and downstream of tsr correspondingly |
This study |
pKC-egfp
|
pKC1139 containing PermE-egfp-fd cassette for egfp overexpression |
This study |
pUC-Sencas9 |
pUC57 carrying a synthetic codon-optimized cas9 gene |
This study |
pKC-cas9 |
pKC1139 containing PermE-Sencas9-fd cassette |
This study |
pKC-cas9-sgRNA |
pKC1139 containing PermE-Sencas9-fd cassette and PermE-sgRNA cassette |
This study |
pkC-CRISPR/Cas9 |
pKC1139 containing PermE-Sencas9-fd cassette, PermE-sgRNA cassette, and homologous arm for gene deletion |
This study |